LKL International Berhad, an investment holding company, manufactures and sells medical and healthcare beds, medical peripherals, and related accessories under the LKL brand name in Malaysia. More Details
Adequate balance sheet and overvalued.
Share Price & News
How has LKL International Berhad's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: LKL is more volatile than 75% of MY stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: LKL's weekly volatility has decreased from 17% to 10% over the past year, but is still higher than 75% of MY stocks.
7 Day Return
MY Medical Equipment
1 Year Return
MY Medical Equipment
Return vs Industry: LKL underperformed the MY Medical Equipment industry which returned -60.3% over the past year.
Return vs Market: LKL underperformed the MY Market which returned -0.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is LKL International Berhad's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StIs The Market Rewarding LKL International Berhad (KLSE:LKL) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
4 months ago | Simply Wall StInvestors Who Bought LKL International Berhad (KLSE:LKL) Shares A Year Ago Are Now Up 295%
5 months ago | Simply Wall StWe're Watching These Trends At LKL International Berhad (KLSE:LKL)
Is LKL International Berhad undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate LKL's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate LKL's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: LKL is unprofitable, so we can't compare its PE Ratio to the MY Medical Equipment industry average.
PE vs Market: LKL is unprofitable, so we can't compare its PE Ratio to the MY market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate LKL's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: LKL is good value based on its PB Ratio (1.2x) compared to the MY Medical Equipment industry average (2.6x).
How is LKL International Berhad forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as LKL International Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has LKL International Berhad performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: LKL is currently unprofitable.
Growing Profit Margin: LKL is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: LKL is unprofitable, and losses have increased over the past 5 years at a rate of 21.1% per year.
Accelerating Growth: Unable to compare LKL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LKL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (41.4%).
Return on Equity
High ROE: LKL has a negative Return on Equity (-3.2%), as it is currently unprofitable.
How is LKL International Berhad's financial position?
Financial Position Analysis
Short Term Liabilities: LKL's short term assets (MYR89.2M) exceed its short term liabilities (MYR5.8M).
Long Term Liabilities: LKL's short term assets (MYR89.2M) exceed its long term liabilities (MYR7.0M).
Debt to Equity History and Analysis
Debt Level: LKL's debt to equity ratio (4.7%) is considered satisfactory.
Reducing Debt: LKL's debt to equity ratio has reduced from 23.5% to 4.7% over the past 5 years.
Debt Coverage: LKL's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if LKL's interest payments on its debt are well covered by EBIT.
What is LKL International Berhad current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate LKL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate LKL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if LKL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LKL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: LKL is not paying a notable dividend for the MY market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of LKL's dividend in 3 years as they are not forecast to pay a notable one for the MY market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ming Lim (39 yo)
Mr. Ming Chang Lim serves as Executive Director at Focus Dynamics Group Berhad since April 30, 2021. He serves as Executive Director at LKL International Berhad since November 16, 2020. He is a Promoter of...
Experienced Management: LKL's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Experienced Board: LKL's board of directors are not considered experienced ( 0.5 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.2%.
LKL International Berhad's company bio, employee growth, exchange listings and data sources
- Name: LKL International Berhad
- Ticker: LKL
- Exchange: KLSE
- Founded: 2015
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: RM153.030m
- Shares outstanding: 566.78m
- Website: https://www.lklbeds.com
Number of Employees
- LKL International Berhad
- Wisma LKL
- No. 3, Jalan BS 7/18
- Seri Kembangan
LKL International Berhad, an investment holding company, manufactures and sells medical and healthcare beds, medical peripherals, and related accessories under the LKL brand name in Malaysia. The company o...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/07/30 18:11|
|End of Day Share Price||2021/07/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.